Surface Pharmaceuticals: Funding, Investors & Team (Sep 2026)
Surface Pharmaceuticals is an owner and operator of a pharmaceutical company intended to provide ophthalmology products. The company's medicines use topical formulations with the patented Klarity delivery vehicle, designed to protect and rehabilitate the ocular surface, enabling patients with dry eye disease to recover on time and properly.
Surface Pharmaceuticals has raised $5.8M across 1 funding round on record, the most recent an undisclosed round of $5.8M announced in Jun 2021.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Surface Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Jun 2021.
Surface Pharmaceuticals Funding Rounds
Surface Pharmaceuticals Founders and Leadership Team
No contact details are on record for this team yet.
Surface Pharmaceuticals Funding Compared to Other Biotechnology Startups
Surface Pharmaceuticals' latest round of $5.8M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Surface Pharmaceuticals in Biotechnology and California City
Companies Similar to Surface Pharmaceuticals
SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…
Solstice Oncology is a clinical stage immuno-oncology company
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…
BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Surface Pharmaceuticals Funding FAQs
What does Surface Pharmaceuticals do?
Surface Pharmaceuticals is an owner and operator of a pharmaceutical company intended to provide ophthalmology products. The company's medicines use topical formulations with the patented Klarity delivery vehicle, designed to protect and rehabilitate the ocular surface, enabling patients with dry eye disease to recover on time and properly.
How much funding has Surface Pharmaceuticals raised?
Surface Pharmaceuticals has raised $5.8M across 1 round on record. The most recent is an undisclosed round of $5.8M announced in Jun 2021.
When did Surface Pharmaceuticals last raise funding?
Surface Pharmaceuticals' most recent funding round on record is an undisclosed round of $5.8M, announced in Jun 2021.
Who is the CEO of Surface Pharmaceuticals?
Kamran Hosseini is listed as CEO at Surface Pharmaceuticals.
Where is Surface Pharmaceuticals headquartered?
Surface Pharmaceuticals is based in California City, California, United States.
How many employees does Surface Pharmaceuticals have?
Surface Pharmaceuticals is in the 1-10 employee band.
How does Surface Pharmaceuticals' funding compare to other Biotechnology startups?
Surface Pharmaceuticals' latest round of $5.8M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's Surface Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Surface Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.